A computer program was used to randomly choose the treatment each participant
got. This helps make sure the groups are chosen fairly. Researchers do this so that
comparing the results of each treatment is as accurate as possible.
The chart below shows the treatments the researchers planned to study.
Benralizumab Placebo
431 participants 229 participants
Benralizumab Placebo
as an injection as an injection
• 1 dose every 4 weeks for 3 doses
• 1 dose 8 weeks later
All of the participants also continued taking
their regular standard of care asthma treatments.
What happened during this study?
The participants were in the study for just over 7 months, but the entire study took
over 2 years to finish.
The study started in July 2017 and ended in September 2019.
5 | Clinical Study Results